Skip to main content
. 2013 Jul 18;8(7):e68767. doi: 10.1371/journal.pone.0068767

Table 1. IC50 characterization of IPK1 and TMC125.

IC50 (nM)
HIV strains TMC125 IPK1
WT 1.4 24
MDRC4 6.8 199
K103N 1.8 1777
Y181C 5.9 >10000
K103N/Y181C 19.3 >10000
V106A 1.3 1.6

Antiviral activity of IPK1 and TMC125 compounds against defined reverse transcriptase resistant mutations using the Monogram Bioscience experimental assay.